Published in Pol Arch Med Wewn on January 12, 2015
Human Urine Proteomics: Analytical Techniques and Clinical Applications in Renal Diseases. Int J Proteomics (2015) 0.76
Is Urinary NGAL Determination Useful for Monitoring Kidney Function and Assessment of Cardiovascular Disease? A 12-Month Observation of Patients with Type 2 Diabetes. Dis Markers (2016) 0.75
Insights into Diabetic Kidney Disease Using Urinary Proteomics and Bioinformatics. J Am Soc Nephrol (2017) 0.75
Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum. J Clin Lipidol (2013) 1.58
Targeting a novel Plasmodium falciparum purine recycling pathway with specific immucillins. J Biol Chem (2004) 1.34
Synthesis of second-generation transition state analogues of human purine nucleoside phosphorylase. J Med Chem (2003) 1.27
Plasmodium falciparum purine nucleoside phosphorylase: crystal structures, immucillin inhibitors, and dual catalytic function. J Biol Chem (2004) 1.26
Influence of electric charge variation at residues 209 and 159 on the interaction of eIF4E with the mRNA 5' terminus. Biochemistry (2004) 1.15
Landscape of the hnRNP K protein-protein interactome. Proteomics (2006) 1.12
Nicotiana tabacum osmotic stress-activated kinase is regulated by phosphorylation on Ser-154 and Ser-158 in the kinase activation loop. J Biol Chem (2006) 1.08
Activating the phosphate nucleophile at the catalytic site of purine nucleoside phosphorylase: a vibrational spectroscopic study. J Am Chem Soc (2004) 1.04
Exploring structure-activity relationships of transition state analogues of human purine nucleoside phosphorylase. J Med Chem (2003) 1.04
Atomic dissection of the hydrogen bond network for transition-state analogue binding to purine nucleoside phosphorylase. Biochemistry (2002) 1.02
A complex containing the CPSF73 endonuclease and other polyadenylation factors associates with U7 snRNP and is recruited to histone pre-mRNA for 3'-end processing. Mol Cell Biol (2012) 1.01
Ionic states of substrates and transition state analogues at the catalytic sites of N-ribosyltransferases. Biochemistry (2003) 0.97
Ion mobility separation coupled with MS detects two structural states of Alzheimer's disease Aβ1-40 peptide oligomers. J Mol Biol (2011) 0.96
The binding constant for amyloid Abeta40 peptide interaction with human serum albumin. Biochem Biophys Res Commun (2007) 0.93
Alzheimer's disease Abeta peptide fragment 10-30 forms a spectrum of metastable oligomers with marked preference for N to N and C to C monomer termini proximity. J Mol Biol (2004) 0.89
A probabilistic framework for peptide and protein quantification from data-dependent and data-independent LC-MS proteomics experiments. OMICS (2012) 0.85
Positions of disulfide bonds and N-glycosylation site in juvenile hormone binding protein. Arch Biochem Biophys (2004) 0.84
Drafting the CLN3 protein interactome in SH-SY5Y human neuroblastoma cells: a label-free quantitative proteomics approach. J Proteome Res (2013) 0.84
Phosphorylation of HopQ1, a type III effector from Pseudomonas syringae, creates a binding site for host 14-3-3 proteins. Plant Physiol (2013) 0.83
A direct determination of the dissociation constant for the Cu(II) complex of amyloid beta 1-40 peptide. Chem Res Toxicol (2010) 0.83
Diffprot - software for non-parametric statistical analysis of differential proteomics data. J Proteomics (2012) 0.82
Casein kinases phosphorylate multiple residues spanning the entire hnRNP K length. Biochim Biophys Acta (2006) 0.81
Analysis of serine proteinase-inhibitor interaction by alanine shaving. Protein Sci (2002) 0.80
Identification of new in vivo phosphosites on lamin Dm - the evidence of heterogeneity of phosphorylation sites in different Drosophila tissues. Nucleus (2011) 0.79
Protein kinase C beta in postischemic brain mitochondria. Mitochondrion (2011) 0.78
Overexpression of juvenile hormone binding protein in bacteria and Pichia pastoris. Protein Expr Purif (2003) 0.78
Relationship between primary aldosteronism and obstructive sleep apnoea, metabolic abnormalities and cardiac structure in patients with resistant hypertension. Endokrynol Pol (2013) 0.78
[Catheter-based renal sympathetic denervation for the treatment of resistant arterial hypertension in Poland - experts consensus statement]. Kardiol Pol (2011) 0.78
Active site contacts in the purine nucleoside phosphorylase--hypoxanthine complex by NMR and ab initio calculations. Biochemistry (2004) 0.77
Can we accurately measure the concentration of clinically relevant vitamin D metabolites in the circulation? The problems and their consequences. Endokrynol Pol (2013) 0.77
N-linked glycosylation of G. mellonella juvenile hormone binding protein - comparison of recombinant mutants expressed in P. pastoris cells with native protein. Biochim Biophys Acta (2011) 0.77
Complement components, proteolysis‑related, and cell communication‑related proteins detected in urine proteomics are associated with IgA nephropathy. Pol Arch Med Wewn (2014) 0.76
LC-MS/MS improves screening towards 21-hydroxylase deficiency. Gynecol Endocrinol (2014) 0.76
Classification of peptide mass fingerprint data by novel no-regret boosting method. Comput Biol Med (2009) 0.76
Proteomic technology in the design of new effective antibacterial vaccines. Expert Rev Proteomics (2009) 0.76
Yeast prion [PSI+] lowers the levels of mitochondrial prohibitins. Biochim Biophys Acta (2009) 0.76
Biochemical properties of endogenous presenilin 1 and presenilin 2 in cultured human B-lymphocytes. Clin Chem Lab Med (2007) 0.76
The Cu(II) complex of Abeta40 peptide in ammonium acetate solutions. Evidence for ternary species formation. Chem Commun (Camb) (2009) 0.75
[Management of familial heterozygous hypercholesterolaemia. Position paper of the Polish Lipid Expert Forum]. Kardiol Pol (2013) 0.75
[Recommendations for prevention of community-acquired pneumonia with bacteremia as the leading form of invasive pneumococcal infections in the population of people over 50 years of age and risk groups above 19 years of age]. Pol Merkur Lekarski (2014) 0.75
[Actual problems of dyslipidaemia treatment in Poland - 2nd Declaration of Sopot. Experts' Group Consensus endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy]. Kardiol Pol (2014) 0.75
Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum. Pol Arch Med Wewn (2013) 0.75
Renal resistive index in patients with true resistant hypertension: results from the RESIST-POL study. Kardiol Pol (2016) 0.75
Assignment of downfield proton resonances in purine nucleoside phosphorylase immucillin-H complex by saturation-transferred NOEs. Biochemistry (2004) 0.75
Modulation of serum levels of sRAGE by bromelain in patients with chronic kidney disease: a pilot study. Pol Arch Med Wewn (2012) 0.75
Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients. Ginekol Pol (2017) 0.75
[Heart failure in advanced age]. Pol Arch Med Wewn (2004) 0.75
Position paper of the working group of three Polish national consultants in internal medicine, gastroenterology, and cardiology on prevention of gastrointestinal complications during antiplatelet treatment. Pol Arch Med Wewn (2009) 0.75